Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of breast cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial

Rupert Bartsch, Maximilian Marhold, J. Garde, María Gión, Manuel Ruíz-Borrego, Richard Greil, María Valero, Antonio Llombart‐Cussac, Juan Garcia, Míriam Arumí, Javier Cortés, Marta Campolier, José A. Guerrero, Felipe Slebe, Elena Martínez-García, Carlos Jiménez‐Cortegana, Marta Vaz-Batista, Felicitas Oberndorfer, Julia Furtner, Thorsten Fuereder, Anna Sophie Berghoff, Matthias Preusser